(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

NH Berlin Alexanderplatz

Apr 24, 2017 8:00 AM - Apr 24, 2017 4:30 PM

Landsberger Allee 26-32, 10249 Berlin, Germany

EU Health Authorities Scientific and Regulatory Advice

NEW OFFERING! The course is built up as a dialogue between industry and regulator perspective and will teach you what authorities pay attention to, what inquiries they make and what they expect to hear from sponsors.

Register Now (Credit Card)

Back to Agenda

SESSION 3: WHAT HAPPENS AFTER THE AGENCY MEETING/FEEDBACK

Session Chair(s)

Birka Lehmann, MD

Birka Lehmann, MD

Senior Expert Drug Regulatory Affairs

Birka Lehmann, Germany

Trine B. Moulvad, MSc

Trine B. Moulvad, MSc

Global RA, Medical Documentation and R&D QA

Lundbeck, Denmark

  • Debrief
  • Meeting minutes
  • What does the advice received mean and how it should be used? How to apply the learnings from the meeting and follow up where necessary
  • Transparency

Speaker(s)

Trine B. Moulvad, MSc

WHAT HAPPENS AFTER THE AGENCY MEETING/FEEDBACK

Trine B. Moulvad, MSc

Lundbeck, Denmark

Global RA, Medical Documentation and R&D QA

Have an account?

Register Now (Credit Card)

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.